Clinical Trial Update: A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia. [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the safety and efficacy of ZS for hyperkalemia has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperkalemia

Drugs mentioned

• ZS

Snippet

Sponsor: AstraZeneca | Conditions: Hyperkalemia | Phase 3 | Status: COMPLETED | Results posted: 2025-05-14